Recently Diagnosed or Relapsed? Stop Looking For a Miracle Cure, and Use Evidence-Based Therapies To Enhance Your Treatment and Prolong Your Remission
Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.
Click the orange button to the right to learn more about what you can start doing today.
“Many people survive their cancers, but end up dying of cardiovascular disease (CVD). New research finds that Cardiovascular Disease risk factors may be overlooked during survivorship care”
Post cancer therapy, cardiovascular disease risk is a reality for life. Multiple myeloma patients who complete their therapy want to forget about their MM and get on with their lives. The reality is that MM patients are cancer survivors for life.
Each one of us must understand the short, long-term and late stage side-effects of his/her therapy. And cardiovascular disease (CVD) is an important possible side-effect of your cancer therapy.
There are a variety of therapies that reduce the risk of cardiovascular disease in myeloma patients. As a long-term MM survivor myself I should know. I developed chronic atrial fibrillationand was diagnosed with chemotherapy-induced heart damage in 2010. I research and study therapies to manage this devestating side effect.
The two key supplements that I take to manage my cardiovascular disease are CoQ10, and Omega 3 Fatty Acids. Research has shown that both of these supplements help my heart function.
Further, I exercise moderately six times a week. When I say moderately I mean moderately. Next, I find heart healthy foods such as dark chocolate. Seriously. Good and good for me.
If you are about to have anthracycline-based chemotherapy, please read the studies linked below and consider supplementing with the brand of CoQ10 supplement that I take daily called Life Extension Super Ubiquinol Coq10.
As a myeloma survivor who developed chemo-induced CVD exactly 15 years after my ASCT, I have researched and written about cardio toxicity as well as the late stage side effect called chemotherapy-induced cardiomyopathy.
“Many people survive their cancers (multiple myeloma), but end up dying of cardiovascular disease (CVD). New research from Wake Forest Baptist Medical Center finds that CVD risk factors may be overlooked during survivorship care…
Kathryn E. Weaver, Ph.D., colleagues surveyed survivors of breast, prostate, colorectal and gynecologic cancers (and multiple myeloma) in search of answers.
“Increasingly, we are concerned about cardiovascular health in long-term cancer survivors, and we believe this is a high-risk group that needs close attention,” lead author Weaver said. “As part of good survivorship health, it’s going to be increasingly important for health care providers to assess and address cardiovascular risk in cancer survivors…
For example, Weaver said there is data showing that early stage breast cancer patients are more likely to die of cardiovascular disease, (CVD) than of breast cancer… some of the treatments cancer patients undergo may put them at higher risk, she said.
clinical studies suggest that (the chemotherapy side effect) anthracycline–induced cardiotoxicity can be prevented by administering coenzyme Q10 during cancer chemotherapy
This blog post is at the top of my “I wish I knew then what I know now” list. CoQ10 can prevent the chemotherapy side effect that has permanently damaged my heart…
Coq10 supplementation during anthracycline administration prevents cardiotoxicity.
Most importantly, according to the evidence-based research linked and excerpted below, “Studies further suggest that Coq10does not interfere with the antineoplastic action of anthracyclines and might even enhance their anticancer effects...”
If I were a parent with a child about to go through anthracycline-based chemotherapy this is all I would have to know to give my child Coq10 supplements. Coq10“Prevents cardiotoxicity and do not interfere with the cancer-killing action of the chemo.”
As a parent I would worry that the researchers discussed in the study linked and excerpted below will take valuable time to invent an expensive test that identifies a genetic propensity to prevent anthracycline-induced cardiotoxicity.
Fortunately I am not a parent of a child with cancer. Unfortunately I underwent Vincristine chemotherapy in ’95 and have lived with chronic atrial fibrillation since 2010.
If you are about to have anthracycline-based chemotherapy, please read the studies linked below and consider supplementing with the brand of CoQ10 supplement that I take daily called Life Extension Super Ubiquinol Coq10.
“Preclinical and clinical studies suggest that anthracycline–induced cardiotoxicity can be prevented by administering coenzyme Q10 during cancer chemotherapy. Studies further suggest that coenzyme Q10 does not interfere with the antineoplastic action of anthracyclines and might even enhance their anticancer effects...
Coenzyme Q10, an essential component of the electron transport system and a potent intracellular antioxidant, appears to prevent damage to the mitochondria of the heart, thus preventing the development of anthracycline–inducedcardiomyopathy…”
” In Nature Genetics, an international team described a gene variant that dials up the risk of heart problems in children treated with the cancer drug anthracycline…
Some of the patients had developed cardiotoxicity-related symptoms while others did not…
Although available treatments have extended the lives of many children with cancer, drug-related side effects such as cardiovascular disease can cause long-term health problems in a subset of these patients. For instance, the team noted, as many as 57 percent of anthracycline-treated children develop asymptomatic cardiac dysfunction, while an estimated 16 percent experience congestive heart failure…
Consequently, there’s ongoing interest in using genetic approaches to dig for factors that mediate the risk of drug-related complications in children treated with anthracycline or other cancer drugs…”
APPIP ERROR: amazonproducts[
AccessDeniedAwsUsers|The Access Key Id AKIAJAJ37JVNL7OUU4CA is not enabled for accessing this version of Product Advertising API. Please migrate your credentials as referred here https://webservices.amazon.com/paapi5/documentation/migrating-your-product-advertising-api-account-from-your-aws-account.html.
]
supplementation during anthracycline administration prevents cardiotoxicity. 